In Silico Insights into the Impact of Deleterious SNPs on the Functioning and Dynamics of TP53 and Its Targeted Therapy by COTI-2 and PRIMA1 in Breast Cancer Patients. UCP Journal of Science & Technology, v. 3, n. 2, p. 31–58, 13 Jul.2026.